Published in Front Pharmacol on June 07, 2017
UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem (2004) 112.47
A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol (1961) 45.34
Improved protein-ligand docking using GOLD. Proteins (2003) 7.94
Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol (1995) 4.91
The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry (1999) 3.98
Molecular and cellular biology of cholinesterases. Prog Neurobiol (1993) 3.01
Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol (1995) 2.95
Medicinal chemical properties of successful central nervous system drugs. NeuroRx (2005) 2.55
Pharmacological properties of the ubiquitous natural product betulin. Eur J Pharm Sci (2006) 2.00
A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry (2001) 1.68
Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders. Phytother Res (2003) 1.63
An antitumor promoter from Moringa oleifera Lam. Mutat Res (1999) 1.54
Anti-AIDS agents. 34. Synthesis and structure-activity relationships of betulin derivatives as anti-HIV agents. J Med Chem (1998) 1.33
Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene (2004) 1.29
Phenolic contents, antioxidant and anticholinesterase potentials of crude extract, subsequent fractions and crude saponins from Polygonum hydropiper L. BMC Complement Altern Med (2014) 1.25
Evaluation of the anxiolytic effects of chrysin, a Passiflora incarnata extract, in the laboratory rat. AANA J (2007) 1.18
Anti-inflammatory, gastroprotective, free-radical-scavenging, and antimicrobial activities of hawthorn berries ethanol extract. J Agric Food Chem (2008) 1.10
Behavioral characterisation of the flavonoids apigenin and chrysin. Fitoterapia (2000) 1.07
Synthesis and anticancer effect of chrysin derivatives. Bioorg Med Chem Lett (2003) 1.06
Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group. Lancet (1995) 1.05
Anti-inflammatory effect of Pimenta racemosa var. ozua and isolation of the triterpene lupeol. Farmaco (2001) 1.05
New therapeutic approaches to Alzheimer's disease. J Clin Psychiatry (1996) 1.03
Antimicrobial activity of the methanolic extract and of the chemical constituents isolated from Newbouldia laevis. Pharmazie (2007) 1.01
Chrysin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression through the inhibition of nuclear factor for IL-6 (NF-IL6) DNA-binding activity. FEBS Lett (2005) 1.00
Investigations of anticholinestrase and antioxidant potentials of methanolic extract, subsequent fractions, crude saponins and flavonoids isolated from Isodon rugosus. Biol Res (2014) 0.99
The pharmacology of galanthamine and its analogues. Pharmacol Ther (1995) 0.99
Quantification of the polyphenols and triterpene acids in chinese hawthorn fruit by high-performance liquid chromatography. J Agric Food Chem (2006) 0.97
Antioxidant and anticholinesterase investigations of Rumex hastatus D. Don: potential effectiveness in oxidative stress and neurological disorders. Biol Res (2015) 0.95
Ginkgo extract or cholinesterase inhibitors in patients with dementia: what clinical trials and guidelines fail to consider. Phytomedicine (2003) 0.94
Comparative chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from Polygonum hydropiper L: A Preliminary anti- Alzheimer's study. Lipids Health Dis (2015) 0.93
Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha). J Clin Pharmacol (2003) 0.92
Inhibition of protein tyrosine phosphatase 1B by lupeol and lupenone isolated from Sorbus commixta. J Enzyme Inhib Med Chem (2009) 0.91
Synthesis, anticholinesterase and antioxidant potentials of ketoesters derivatives of succinimides: a possible role in the management of Alzheimer's. Chem Cent J (2015) 0.90
[Therapeutic effectiveness of Crataegus]. Fortschr Med (1996) 0.88
Hepatoprotective effect of lupeol and lupeol linoleate on tissue antioxidant defence system in cadmium-induced hepatotoxicity in rats. Fitoterapia (2001) 0.88
Antiprotozoal activity of the constituents of Rubus coriifolius. Phytother Res (2003) 0.85
Antiviral activity of betulin, betulinic and betulonic acids against some enveloped and non-enveloped viruses. Fitoterapia (2003) 0.85
Lupeol, a triterpene, inhibits early responses of tumor promotion induced by benzoyl peroxide in murine skin. Pharmacol Res (2001) 0.84
Screening and structural characterization of alpha-glucosidase inhibitors from hawthorn leaf flavonoids extract by ultrafiltration LC-DAD-MS(n) and SORI-CID FTICR MS. J Am Soc Mass Spectrom (2009) 0.83
Pharmacologic management of Alzheimer's disease. Clin Geriatr Med (1998) 0.80
Profile of gantenerumab and its potential in the treatment of Alzheimer's disease. Drug Des Devel Ther (2013) 0.77
Beta-sitosterol-3-O-beta-D-glucopyranoside: a eukaryotic DNA polymerase lambda inhibitor. J Steroid Biochem Mol Biol (2006) 0.76
Hawthorn ethanolic extracts with triterpenoids and flavonoids exert hepatoprotective effects and suppress the hypercholesterolemia-induced oxidative stress in rats. Iran J Basic Med Sci (2015) 0.76
Neuroprotective and Anti-Aging Potentials of Essential Oils from Aromatic and Medicinal Plants. Front Aging Neurosci (2017) 0.75